 | articles |
Browse Journal of Hematology & Oncology by date
| | | October 2008 - Browse articles | Review
First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting
Andrea Molckovsky, Lillian L Siu
Journal of Hematology & Oncology 2008, 1:20 (29 October 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Research
Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells
Che K Lim, Li Sun, Qi Feng, Ping Law, Wei T Chua, Shy N Lim, William YK Hwang
Journal of Hematology & Oncology 2008, 1:19 (23 October 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Case report
Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report
Brian J So, Tanios Bekaii-Saab, Mark A Bloomston, Tushar Patel
Journal of Hematology & Oncology 2008, 1:18 (17 October 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Research
Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study
Eman Mosad, Hosny B Hamed, Rania M Bakry, Azza M Ezz-Eldin, Nesrine M Khalifa
Journal of Hematology & Oncology 2008, 1:17 (17 October 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Review
Novel therapies in breast cancer: what is new from ASCO 2008
David Chu, Janice Lu
Journal of Hematology & Oncology 2008, 1:16 (1 October 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles]
Review
P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia
Shundong Cang, Delong Liu
Journal of Hematology & Oncology 2008, 1:15 (1 October 2008)
[Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
|
|  
|
